Retour
22
Fourchette du Jour
110,03 €
115,24 €
Fourchette 52 Semaines
96,43 €
160,27 €
Volume
1 074 492
Moyenne 50J / 200J
127,46 €
/
129,95 €
Clôture Précédente
112,02 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 24,8 | 0,3 |
| P/B | 4,8 | 2,9 |
| ROE % | 20,6 | 3,7 |
| Net Margin % | 18,8 | 3,8 |
| Rev Growth 5Y % | 2,4 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
165,00 €
+44.5%
Low: 130,00 €
High: 180,00 €
P/E Prévisionnel
18,8
BPA Prévisionnel
5,97 €
Croissance BPA (est.)
+0,0%
CA Est.
7,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,58 €
8,47 € – 8,69 €
|
9,3 B | 1 |
| FY2029 |
8,04 €
7,93 € – 8,14 €
|
8,8 B | 1 |
| FY2028 |
7,29 €
6,75 € – 7,71 €
|
8,4 B | 5 |
Points Clés
Revenue grew 2,40% annually over 5 years — modest growth
ROE of 20,62% indicates high profitability
Net margin of 18,75% shows strong profitability
Debt/Equity of 0,50 — conservative balance sheet
Generating 1,15B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,33%
Croissance
Revenue Growth (5Y)
2,40%
Revenue (1Y)6,73%
Earnings (1Y)1,09%
FCF Growth (3Y)-11,59%
Qualité
Return on Equity
20,62%
ROIC10,99%
Net Margin18,75%
Op. Margin21,29%
Sécurité
Debt / Equity
0,50
Current Ratio1,96
Interest Coverage13,21
Valorisation
P/E Ratio
24,79
P/B Ratio4,79
EV/EBITDA22,90
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,73% | Revenue Growth (3Y) | 0,84% |
| Earnings Growth (1Y) | 1,09% | Earnings Growth (3Y) | 2,51% |
| Revenue Growth (5Y) | 2,40% | Earnings Growth (5Y) | 1,87% |
| Profitability | |||
| Revenue (TTM) | 6,95B | Net Income (TTM) | 1,30B |
| ROE | 20,62% | ROA | 10,24% |
| Gross Margin | 52,43% | Operating Margin | 21,29% |
| Net Margin | 18,75% | Free Cash Flow (TTM) | 1,15B |
| ROIC | 10,99% | FCF Growth (3Y) | -11,59% |
| Safety | |||
| Debt / Equity | 0,50 | Current Ratio | 1,96 |
| Interest Coverage | 13,21 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 24,79 | P/B Ratio | 4,79 |
| P/S Ratio | 4,65 | PEG Ratio | 9,41 |
| EV/EBITDA | 22,90 | Dividend Yield | 0,01% |
| Market Cap | 32,30B | Enterprise Value | 33,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,95B | 6,51B | 6,83B | 6,85B | 6,32B |
| Net Income | 1,30B | 1,29B | 1,24B | 1,25B | 1,21B |
| EPS (Diluted) | 4,57 | 4,43 | 4,19 | 4,18 | 3,94 |
| Gross Profit | 3,64B | 3,54B | 3,47B | 3,72B | 3,41B |
| Operating Income | 1,48B | 1,49B | 1,35B | 1,62B | 1,35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,73B | 11,85B | 10,76B | 10,53B | 10,71B |
| Total Liabilities | 5,99B | 5,95B | 4,92B | 5,23B | 5,32B |
| Shareholders' Equity | 6,74B | 5,90B | 5,85B | 5,31B | 5,39B |
| Total Debt | 3,35B | 3,57B | 2,74B | 2,77B | 2,73B |
| Cash & Equivalents | 1,79B | 1,33B | 1,59B | 1,05B | 1,48B |
| Current Assets | 4,59B | 3,96B | 4,19B | 3,78B | 3,80B |
| Current Liabilities | 2,35B | 1,90B | 1,60B | 1,86B | 1,71B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#960 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026